MoS says literacy and education must be reimagined as instruments of empowerment (See 'Corp Brief') Workshop on Data Harmonisation for Data Driven Governance held (See 'Corp Brief') DAHD strengthens Surveillance, Vaccination and Disease-Control Measures (See 'Corp Brief') PM-SETU strengthens Industry-Led ITI Transformation (See 'Corp Brief') Competition Act - Allegations of anti-competitive agreements and abuse of dominant position cannot be sustained on basis of information which is generic, speculative, lacking in foundational facts & not backed by cogent evidence: CCI (See 'Legal Desk') DFPD and FCI sign MoU for to Strengthen Efficiency in Foodgrain Management (See 'Corp Brief') STPI Organises Electropreneur Summit 2026 at IIIT-Delhi (See 'Corp Brief') India-Japan Joint Working Group Meeting on Forests held at Bengaluru (See 'Corp Brief') AI keeps an Eye on 'Cattle of the Hills' (See 'Corp Brief') IBC - Act of IRP in releasing direct payments to an un-engaged secondary advocate without a formal direct engagement letter, independent invoices in payee's name, violates professional standards & regulatory requirements under IBC Code of Conduct, irrespective of subsequent ratification by CoC: IBBI (See 'Legal Desk') Next-Gen Aquaculture in India: Harnessing RAS and Bio-floc Technology in Blue Economy (See 'Corp Brief') Fighting Air Pollution is continuous Programme: EFCC Secretary (See 'Corp Brief') From Struggles to Success: KVIC is Inspiring Entrepreneurial Journeys (See 'Corp Brief') NI Act is not primarily punitive rather is compensatory in nature, with focus on recovery of amount in question: HC (See 'Legal Desk') India should target 10 Million Medical Value Tourists Annually: Goyal (See 'Corp Brief') CIL's daily Average Production Rises 35% (See 'Corp Brief') e-FAST India launches PACT to support accelerated zero-emission freight deployment in India (See 'Corp Brief') Chouhan reviews action plan for strengthening KVKs through greater State participation (See 'Corp Brief') CPC - leave granted u/s Clause XII of the Letters Patent confers jurisdiction exclusively on High Court & does not bind or preserve the territorial jurisdiction of a subordinate civil court upon transfer: HC (See 'Legal Desk') Minister says early industry participation can make technologies market-ready (See 'Corp Brief') Dynamic Local Level Planning imperative for documenting Local Biodiversity: Yadav (See 'Corp Brief') National Zoological Park Organises Sunday Bird, Butterfly and Dragonfly Walks to Promote Science (See 'Corp Brief') SEBI - Writ court's intervention is required in a private contractual dispute between petitioner & broker where any contractual or statutory remedies available under SEBI Act is not invoked: HC (See 'Legal Desk') 1st Batch of Corporate Mitra Course Commences with 2879 Learners registered (See 'Corp Brief') SAIL posts strong sales and production growth in August 2026 (See 'Corp Brief') SEBI - Any notice or assessment order is invalid where passed in respect of an entity that has been struck off Register of Companies & has since been dissolved: SEBI (See 'Legal Desk') MoS felicitates 'Team India School Children' for Historic Best-Ever Performance (See 'Corp Brief') Coal India Output and Dispatch Set to Accelerate as Monsoon Effect Wanes (See 'Corp Brief') Wow! 7.8% growth but it also does not reveal many things! (See CORP EINSICHT)

Print

'Cohort Connect 2025' to be India's Largest evidence-based study on Genetic

Published: Nov 14, 2025

By TIOLCorplaws News Service

NEW DELHI, NOV 14, 2025: ON the eve of World Diabetes Day tomorrow, Union Minister of State (Independent Charge) for Science & Technology, MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh today launched "Phenome National Conclave on Longitudinal Cohort Studies: Cohort Connect 2025", at CSIR–IMMT, here.

Cohort Connect is said to be India's largest evidence-based study on Genetic, Lifestyle and Environmental drivers of Disease.

Delivering the inaugural address, Dr. Jitendra Singh said that the discussion taking place a day before World Diabetes Day carries special relevance, as metabolic disorders like diabetes are rapidly emerging as a major national health challenge. He emphasised that diabetes today represents not just a clinical condition but a complete spectrum of vascular, neurological, and renal complications, making scientific research in this domain critical for national planning.

On the eve of World Diabetes Day, Dr. Jitendra Singh said that India's fight against diabetes and other rising metabolic disorders requires Indian data for Indian solutions, supported by long-term scientific evidence.

The Minister recalled that metabolic disorders, especially Type-2 diabetes, once considered region-specific, have now spread across the country due to lifestyle transitions and changing environmental patterns, turning what was earlier a South India–predominant condition into a pan-India challenge. He emphasized that India continues to deal simultaneously with both communicable and non-communicable diseases, and the reciprocal link between diabetes and infections such as tuberculosis requires integrated policy responses rather than compartmentalised programmes.

Dr. Jitendra Singh underscored that India's phenotypic uniqueness has been acknowledged for decades, but could never be scientifically validated due to limited genomic and epidemiological infrastructure. With initiatives like CSIR-led Phenome India and the large-scale longitudinal cohort studies being undertaken, India now can accurately capture how genetics, environment, diet, and lifestyle shape disease predisposition in Indian populations.

The Minister noted that even Indians living abroad for generations show distinctive susceptibility to metabolic disorders, highlighting the fundamental role of inherited traits.

The Minister shared clinical and historical insights illustrating how global medical understanding has evolved- from pre-insulin starvation-era diabetes management to today's genetic therapies, and urged caution in adopting new drugs and technologies without long-term evidence suited to Indian populations. He recalled that refined oils were once promoted as heart-friendly, only to be later linked with rising coronary artery disease in India, reinforcing the need for rigorous, long-term, India-specific studies before public health recommendations are made.

Highlighting Government initiatives, Dr. Jitendra Singh said that both CSIR and the Department of Biotechnology are working actively on human genome sequencing, with nearly 10,000 human genomes already sequenced and the target of one million genomes progressing rapidly. He also mentioned India's first successful haemophilia trial with indigenously developed Factor VIII, underscoring India's rising capabilities in advanced biomedical research.

Dr Jitendra Singh added that the Government is simultaneously working on vaccines for diseases like dengue, malaria, and tuberculosis, while AI-driven diagnostics, digital health platforms and quantum-enabled solutions are increasingly becoming part of India's medical ecosystem.

The Minister reiterated that with 70% of India's population below 40, prevention must be the central pillar of India's future health strategy. A robust cohort study ecosystem, he said, will generate actionable datasets for preventive, prophylactic and therapeutic pathways tailored to Indian needs. He appreciated CSIR institutions, project investigators, and private-sector partners for creating a platform that integrates science, evidence creation, and translational application through MoUs and venture collaborations.

Dr. Jitendra Singh concluded by stating that India's health status in 2047 will define the vision of Viksit Bharat, and scientific initiatives like Phenome India and Cohort Connect 2025 would serve as foundational pillars in achieving that goal. Citing Hippocrates, he said that even without tools or medicines, a doctor's knowledge can heal; similarly, India's collective scientific wisdom will drive its health transformation in the coming decades.

The inaugural session was attended by Dr. Ramanuj Narayan, Director, CSIR–IMMT, Dr. Maiti (CSIR–IGIB), Dr.Kooti, Dr. Debashish, senior scientists, project investigators, and media representatives. They briefed the press on the objectives and emerging insights from the Phenome India longitudinal cohort, along with the agenda of the upcoming National Conclave on Longitudinal Cohort Studies: Cohort Connect 2025, scheduled to be held at CSIR–IMMT, Bhubaneswar.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.